Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 51, Issue 5, 2011, Pages 411-415

  Fridén, Barbro ^a   Sjöblom, Peter ^b   Menezes, Judith ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c Fertilitetscentrum   (Sweden)

Author keywords

age factor; anti Mullerian hormone; fertilisation in vitro; infertility; ovary

Indexed keywords

ESTRADIOL; GONADOTROPIN; MUELLERIAN INHIBITING FACTOR;

ADULT; ARTICLE; EMBRYO TRANSFER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MAJOR CLINICAL STUDY; NIDATION; OOCYTE RETRIEVAL; OVARIAN RESERVE; PREGNANCY OUTCOME; PREGNANCY RATE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE; ULTRASOUND;

ADULT; AGE FACTORS; ANTI-MULLERIAN HORMONE; BIOLOGICAL MARKERS; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; ROC CURVE; SPERM INJECTIONS, INTRACYTOPLASMIC; TREATMENT OUTCOME;

EID: 80054026495     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2011.01374.x     Document Type: Article

References (24)

1. Official statistics of Sweden. Statistics-Health and Diseases, Pregnancies, deliveries and newborn infants, The Swedish Medical Birth Register 1973-2006. Stockholm: Socialstyrelsen; 2008 June 44 p.
2. Statistical Office of the European Communities (Eurostat). Mean age of women at childbearing-[tps00017]. [Accessed 17 March 2011.] Available from
3. Mathews TJ, Hamilton BE,. Delayed Childbearing: More Women are having their First Child Later in Life. Hyattsville, MD: National Center for Health Statistics. NCHS data brief, no 21. 2009.
4. Wang YA, Chambers GM, Sullivan EA,. Assisted Reproductive Technology in Australia and New Zealand 2008. Assisted reproduction technology series no. 14. Cat. no. PER 49. Canberra: AIHW, 2010.
5. Human Fertilisation and Embryology Authority. Long-term trends data-patients treated. [Accessed 17 March 2011.]. Available from
6. Human Fertilisation and Embryology Authority. A long term analysis of the HFEA Register data 1991-2006. [Accessed 17 Mar 2011.]. Available from.
7. Broekmans FJ, Knauff EA, te Velde ER, et al. Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab. 2007; 18: 58-65. (Pubitemid 46275460)
8. Broer SL, Mol BW, Hendriks D, Broekmans FJ,. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril 2009; 91: 705-714.
9. La Marca A, Sighinolfi G, Radi D, et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update. 2010; 16: 113-130.
10. Broer SL, Mol B, Dõlleman M, et al. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome. Curr Opin Obstet Gynecol 2010; 22: 193-201.
11. Weenen C, Laven JS, Von Bergh AR, et al. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004; 10: 77-83. (Pubitemid 38196508)
12. Hansen KR, Hodnett GM, Knowlton N, Craig LB,. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011; 95: 170-175.
13. Cook CL, Siow Y, Taylor S, Fallat ME,. Müllerian-inhibiting substance during the menstrual cycle. Fertil Steril 2000; 73: 859-861.
14. La Marca A, Stabile G, Artenisio AC, Volpe A,. Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod 2006; 21: 3103-3107. (Pubitemid 44811610)
15. Hehenkamp WJ, Looman CW, Themmen AP, et al. Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006; 91: 4057-4063. (Pubitemid 44536885)
16. Fréour T, Mirallié S, Bach-Ngohou K, et al. Measurement of serum anti-Müllerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta 2007; 375: 162-164. (Pubitemid 44584224)
17. Kumar A, Kalra B, Patel A, et al. Development of a second generation anti-Müllerian hormone (AMH) ELISA. J Immunol Methods 2010; 362: 51-59.
18. Australian Health Ethics Committee. When does quality assurance in health care require independent ethical review? Advice to Institutions, Human Research Ethics Committees and Health Care Professionals (2003). [Accessed 17 March 2011]. Available from.
19. Loong TW,. Understanding sensitivity and specificity with the right side of the brain. BMJ 2003; 327 (7417): 716-719.
20. Weghofer A, Dietrich W, Barad Dh, Gleicher N,. Live birth chances in women with extremely low-serum anti-Mullerian hormone levels. Hum Reprod 2011; 26: 1905-1909.
21. Tremellen K, Kolo M,. Serum anti-Mullerian hormone is a useful measure of quantitative ovarian reserve but does not predict the chances of live-birth pregnancy. Aust N Z J Obstet Gynaecol 2010; 50: 568-572.
22. Muttukrishna S, McGarrigle H, Wakim R, et al. Antral follicle count, anti-Mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? Br J Obstet Gynaecol 2005; 112: 1384-1390. (Pubitemid 43961267)
23. Jayapraskasan K, Campbell B, Hopkisson J, et al. A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three-dimensional ultrasound determinants of ovarian reserve in the prediction of poor response to controlled ovarian stimulation. Fertil Steril 2010; 93: 855-864.
24. Van Disseldorp J, Lambalk CB, Kwee J, et al. Comparison of inter- and intra-cycle variability of anti-Mullerian hormone and antral follicle counts. Hum Reprod 2011; 25: 221-227.